Barluenga; Sofia

Patent Applications and Registrations

Patent applications and USPTO patent grants for Barluenga; Sofia.The latest application filed is for "synthesis of resorcylic acid lactones useful as therapeutic agents".

Company Profile

3.12.18

Barluenga; Sofia - Strasbourg FR
Barluenga; Sofia - Nyon CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Synthesis Of Resorcylic Acid Lactones Useful As Therapeutic Agents App 20190359585 - WINSSINGER; Nicolas ; et al.	2019-11-28
Synthesis of resorcylic acid lactones useful as therapeutic agents Grant 10,239,856 - Winssinger , et al.	2019-03-26
Pochoxime Conjugates Useful For The Treatment Of Hsp90 Related Pathologies App 20170174669 - WINSSINGER; Nicolas ; et al.	2017-06-22
Synthesis Of Resorcylic Acid Lactones Useful As Therapeutic Agents App 20160075677 - Winssinger; Nicolas ; et al.	2016-03-17
Pochoxime Conjugates Useful For The Treatment Of Hsp90 Related Pathologies App 20150374680 - Winssinger; Nicolas ; et al.	2015-12-31
Synthesis of resorcylic acid lactones useful as therapeutic agents Grant 9,051,302 - Winssinger , et al. June 9, 2	2015-06-09
Method Of Preparing An Adduct App 20140200161 - WINSSINGER; Nicolas ; et al.	2014-07-17
Macrocyclic Prodrug Compounds Useful As Therapeutics App 20140135290 - HECK; James ; et al.	2014-05-15
Method of preparing an adduct Grant 8,716,191 - Winssinger , et al. May 6, 2	2014-05-06
Pochoxime Conjugates Useful For The Treatment Of Hsp90 Related Pathologies App 20140031302 - Winssinger; Nicolas ; et al.	2014-01-30
Compositions and methods comprising analogues of radicicol A Grant 8,513,440 - Winssinger , et al. August 20, 2	2013-08-20
Macrocyclic compounds useful as inhibitors of kinases and HSP90 Grant 8,450,305 - Winssinger , et al. May 28, 2	2013-05-28
Irreversible Inhibitors Useful For The Treatment Of Kinase-related Pathologies App 20130053434 - Winssinger; Nicolas ; et al.	2013-02-28
Treatment of neurofibromatosis with radicicol and its derivatives Grant 8,329,683 - Chen , et al. December 11, 2	2012-12-11
Method Of Preparing An Adduct App 20120115751 - Winssinger; Nicolas ; et al.	2012-05-10
Macrocyclic Compounds Useful As Inhibitors Of Kinases And Hsp90 App 20120077775 - WINSSINGER; Nicolas ; et al.	2012-03-29
Macrocyclic compounds useful as inhibitors of kinases and HSP90 Grant 8,067,412 - Winssinger , et al. November 29, 2	2011-11-29
Synthesis Of Resorcylic Acid Lactones Useful As Therapeutic Agents App 20110217335 - Winssinger; Nicolas ; et al.	2011-09-08
Macrocyclic Prodrug Compounds Useful as Therapeutics App 20110190237 - Heck; James ; et al.	2011-08-04
Treatment Of Neurofibromatosis With Radicicol And Its Derivatives App 20100292218 - CHEN; Ruihong ; et al.	2010-11-18
Compositions And Methods Comprising Analogues Of Radicicol A App 20100233279 - Winssinger; Nicolas ; et al.	2010-09-16
Macrocyclic compounds useful as inhibitors of kinases and HSP90 App 20080146545 - Winssinger; Nicolas ; et al.	2008-06-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.